Exenatide for once-weekly administration
- PMID: 22789767
- DOI: 10.1136/dtb.2012.06.0115
Exenatide for once-weekly administration
Abstract
▾Exenatide is a glucagon-like peptide 1 (GLP-1) agonist used in the management of people with type 2 diabetes. A twice-daily injectable formulation (▾Byetta - Eli Lilly) was licensed in 2006. ▾Bydureon (Eli Lilly) is a prolonged-release injectable formulation that allows once-weekly administration. Here we discuss the place of Bydureon in the management of type 2 diabetes mellitus.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical